Acta anaesthesiologica Scandinavica
-
Acta Anaesthesiol Scand · Nov 2005
Randomized Controlled Trial Multicenter Study Comparative StudyThe post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty.
Lumiracoxib is a novel selective cyclooxygenase-2 (COX-2) inhibitor in development for the treatment of chronic and acute pain. ⋯ Lumiracoxib is an effective alternative to traditional non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of post-operative pain.